Summary Masimo Corporation (Masimo) is a global medical technology company. It manufactures and distributes non-invasive patient monitoring technologies such as medical devices and a broad range of sensors to improve patient care. Signal Extraction Technology (SET) is the company's lead technology that helps detect life threatening events. Other technologies of Masimo include Pulse CO-Oximetry which allows noninvasive and continuous monitoring of blood constituents, brain and breath; and Patient SafetyNet, a remote monitoring and wireless clinician notification system. The company's key products include pulse oximeters, patient monitors, patient cables, central monitoring systems, specialty sensors, circuit boards, remote-alarm, and monitoring solutions. It markets these products directly and through distributors and original equipment manufacturers (OEMs) to hospitals, emergency medical services (EMS), physician offices, veterinarians, long term care facilities, and consumers market. The company operates in various markets across North and South America, Europe, the Middle East, Africa, Asia, and Australia. Masimo is headquartered in Irvine, California, the US. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Masimo Corporation - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 Masimo Corporation Company Snapshot 6 Masimo Corporation Company Overview 6 Masimo Corporation Pipeline Products and Clinical Trials Overview 7 Masimo Corporation - Pipeline Analysis Overview 9 Business Description 9 Key Facts 10 Masimo Corporation - Major Products and Services 11 Masimo Corporation Pipeline Products by Development Stage 13 Masimo Corporation Pipeline Products Overview 15 Adaptive Threshold Alarm 15 Adaptive Threshold Alarm Product Overview 15 Eve Newborn Screening Application For Radical-7 Pulse CO-Oximeter 16 Eve Newborn Screening Application For Radical-7 Pulse CO-Oximeter Product Overview 16 Halo Index 17 Halo Index Product Overview 17 iSpO2 Rx- Professional Version 18 iSpO2 Rx- Professional Version Product Overview 18 Masimo rainbow SET - Oxygen Reserve Index 19 Masimo rainbow SET - Oxygen Reserve Index Product Overview 19 Masimo rainbow SET - SpfO2 20 Masimo rainbow SET - SpfO2 Product Overview 20 Masimo rainbow SET Pulse CO-Oximetry - RRp 21 Masimo rainbow SET Pulse CO-Oximetry - RRp Product Overview 21 O3 Regional Oximetry 22 O3 Regional Oximetry Product Overview 22 Rainbow DCI-mini 23 Rainbow DCI-mini Product Overview 23 Rainbow Universal ReSposable SuperSensor 24 Rainbow Universal ReSposable SuperSensor Product Overview 24 Root Iris Display App 25 Root Iris Display App Product Overview 25 Masimo Corporation - Key Competitors 26 Masimo Corporation - Key Employees 27 Masimo Corporation - Key Employee Biographies 28 Masimo Corporation - Locations And Subsidiaries 29 Head Office 29 Other Locations & Subsidiaries 29 Recent Developments 33 Masimo Corporation, Recent Developments 33 Mar 31, 2016: New Clinical Study Reports Relationship Between Masimo's Oxygen Reserve Index (ORI) and Arterial Partial Pressure of Oxygen During Surgery 33 Mar 17, 2016: New Study Reports on Accuracy of Masimo's Blue Sensors at Saturations Below 85% in Children with Cyanotic Congenital Heart Disease 33 Mar 02, 2016: Masimo Introduces SafetyNet Surveillance at HIMSS16 34 Mar 01, 2016: Masimo Announces Iris Gateway at HIMSS16 34 Feb 25, 2016: Manipal Hospitals is the First in India to Adopt Masimo Patient SafetyNet 35 Feb 23, 2016: Masimo Reports Fourth Quarter and Fiscal Year 2015 Financial Results 35 Feb 17, 2016: Masimo Announces FDA 510(k) Clearance for Root with Noninvasive Blood Pressure and Temperature 36 Feb 12, 2016: Masimo's rainbow Acoustic Monitoring was Associated with Fewer Alarm Events During Planned Moderate Sedation in New Clinical Study 36 Feb 04, 2016: In New Clinical Study Masimo's Oxygen Reserve Index Helps Clinicians Detect Impending Desaturation in Pediatric Patients 37 Jan 21, 2016: New Study Shows Utility of Masimo rainbow Acoustic Monitoring 38 Appendix 39 Methodology 39 About GlobalData 39 Contact Us 39 Disclaimer 39
List of Tables
Masimo Corporation Pipeline Products and Clinical Trials Overview 7 Masimo Corporation Pipeline Products by Equipment Type 7 Masimo Corporation Pipeline Products by Indication 8 Masimo Corporation, Key Facts 10 Masimo Corporation, Major Products and Services 11 Masimo Corporation Number of Pipeline Products by Development Stage 13 Masimo Corporation Pipeline Products Summary by Development Stage 14 Adaptive Threshold Alarm - Product Status 15 Adaptive Threshold Alarm - Product Description 15 Eve Newborn Screening Application For Radical-7 Pulse CO-Oximeter - Product Status 16 Eve Newborn Screening Application For Radical-7 Pulse CO-Oximeter - Product Description 16 Halo Index - Product Status 17 Halo Index - Product Description 17 iSpO2 Rx- Professional Version - Product Status 18 iSpO2 Rx- Professional Version - Product Description 18 Masimo rainbow SET - Oxygen Reserve Index - Product Status 19 Masimo rainbow SET - Oxygen Reserve Index - Product Description 19 Masimo rainbow SET - SpfO2 - Product Status 20 Masimo rainbow SET - SpfO2 - Product Description 20 Masimo rainbow SET Pulse CO-Oximetry - RRp - Product Status 21 Masimo rainbow SET Pulse CO-Oximetry - RRp - Product Description 21 O3 Regional Oximetry - Product Status 22 O3 Regional Oximetry - Product Description 22 Rainbow DCI-mini - Product Status 23 Rainbow DCI-mini - Product Description 23 Rainbow Universal ReSposable SuperSensor - Product Status 24 Rainbow Universal ReSposable SuperSensor - Product Description 24 Root Iris Display App - Product Status 25 Root Iris Display App - Product Description 25 Masimo Corporation, Key Employees 27 Masimo Corporation, Key Employee Biographies 28 Masimo Corporation, Other Locations 29 Masimo Corporation, Subsidiaries 30
List of Figures
Masimo Corporation Pipeline Products by Equipment Type 8 Masimo Corporation Pipeline Products by Development Stage 13
Global LCP (Liquid Crystal Polymer) industry is forecasted to reach USD 1.23 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing trend towards developing militarized components and connectors are likely to drive the demandRead More...
Global integrated systems market is projected to reach USD 24 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to re-evaluate data center infrastructure is expected to boost the demand. Change in trend from mainRead More...
Global polymethyl methacrylate (PMMA) market size is likely to be valued at USD 11.65 billion by 2022; as per a new research report by Radiant Insights, Inc. Increasing spending on advertising & marketing for building strong brand equity and productRead More...
Global heat transfer fluids market size is likely to be valued at USD 3.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing demand for for heat recovery management in industries such as metal processing, pharmaceuticaRead More...
Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanomRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.